AstraZeneca held talks with Bristol Myers Squibb on $400 billion megadeal, source says - Reuters
AstraZeneca held talks with Bristol Myers Squibb on $400 billion megadeal, source says Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
All Coverage
<a href="https://news.google.com/rss/articles/CBMizAFBVV95cUxOWTM3b3YyclowY0NiOHZsQ0VWaElaZm5IVmZpRGN6TG9DemlkNDR5LTNYb0VtRm8zS0tENWtDekRSZHlFN3FnUmd2SHhhUVFmcE82dnQwNTByU0dwck1keWQwWnRXYkt2ajd4UEhuVXZaXzZmb3RWUnlwUkhYNXNHTld6Nzl2WVpvdjVwbFZFeGw1MUhRczBNemZZQVhCV0xCeWtScl9LNFd0VVByZXBwTWdZYVBzbmNwOWlXem1MRFUyZTZyRmdWbVdaS04?oc=5" target="_blank">AstraZeneca held talks with Bristol Myers Squibb on $400 billion megadeal, source says</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
AstraZeneca to invest $2 billion in Summit Therapeutics for cancer drug tie-up - Reuters
AstraZeneca to invest $2 billion in Summit Therapeutics for cancer drug tie-up Reuters
September 28, 2026 at 10:15 PMMerck licenses SciBrunch cancer drug in deal worth up to $2.13 billion - Reuters
Merck licenses SciBrunch cancer drug in deal worth up to $2.13 billion Reuters
September 28, 2026 at 04:14 PMAstraZeneca, Daiichi Sankyo partner with Summit to test cancer drug combination - Reuters
AstraZeneca, Daiichi Sankyo partner with Summit to test cancer drug combination Reuters
October 2, 2026 at 06:58 AMNovartis strikes up to $7.8 billion mRNA deal with China's Abogen - Reuters
Novartis strikes up to $7.8 billion mRNA deal with China's Abogen Reuters
October 2, 2026 at 10:57 AMBayer to invest $2.2 billion in new US pharma site - Reuters
Bayer to invest $2.2 billion in new US pharma site Reuters
October 2, 2026 at 07:19 PMSanofi to pay Regeneron $1 billion upfront in expanded immunology deal - Reuters
Sanofi to pay Regeneron $1 billion upfront in expanded immunology deal Reuters
October 1, 2026 at 05:17 AM